NURS 6630 Self Assessment Neurobiology and Medication Adherence Concepts<\/span><\/h2>\n

Sample Answer for NURS 6630 Self Assessment Neurobiology and Medication Adherence Concepts Included After Question<\/strong><\/h2>\n

When building a house, contractors and architects rely on a blueprint to help determine what features and structures are needed to support the house and provide those features sought after by potential buyers. If a potential error occurs in the construction of a support beam, for example, it is likely that the house will sustain damage and, possibly, crumble.<\/span>\u00a0<\/span><\/p>\n

In much the same way, the features and structures of your brain provide a blueprint that help to support your body and provide the mechanisms with which to sustain your well-being. Individuals who suffer from mental illness, according to the fundamental premise of psychiatric neuroscience, are a result of abnormal brain function. Yet, as advancements in neuroimaging and genetics emerge, a whole new understanding of how to address mental illness remains for the psychiatric nurse practitioner (PNP). Neuroimaging and genetic techniques help provide insights, such as a blueprint of the brain, for detailing how the brain\u2019s structure and wiring is functioning.<\/span>\u00a0<\/span><\/p>\n

By determining what functions and structures of the brain or central nervous system are implicated in psychopathologies observed PNPs are able to synthesize biological explanations into treatment protocols for sustained, positive patient outcomes. A solid foundation and understanding of the functions and structures of the central nervous system is the first pillar of solidifying your understanding of psychopharmacology.<\/span>\u00a0<\/span><\/p>\n

What’s Happening This Module?<\/span><\/b>\u00a0<\/span><\/h2>\n

This course is composed of three separate modules covering 11 weeks of content. Each module consists of an overarching topic in which each week within the module includes specific subtopics for learning. Module 1,\u202fIntroduction to Neuroanatomy and Adherence, is a 3-week module. During Week 1, you will review foundational aspects of neuroanatomy as they relate to psychopharmacology. You will examine your knowledge of these foundational aspects of neuroanatomy by completing a Short Answer Assessment. During Week 2, you will explore neurotransmitters and receptor theory as they apply to psychopharmacology. You will engage in a Discussion with your colleagues on foundational neuroscience. In Week 3, you will examine medication adherence and strategies to mitigate non-adherence as it applies to specific treatment plans for patients. You will then complete a Quiz to test your knowledge of the entire module.\u202f<\/span>\u00a0<\/span><\/p>\n\n\n\n\n\n\n\n

What do I have to do?<\/span><\/b>\u202f \u202f\u202f<\/span>\u00a0<\/span><\/td>\n	When do I have to do it?<\/span><\/b>\u202f \u202f\u202f<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Review your Learning Resources.<\/span>\u00a0<\/span><\/td>\n	Days 1\u20137, Weeks 1, 2, and 3<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Assignment: Short Answer Assessment<\/span>\u00a0<\/span><\/td>\n	Submit your Assignment by\u202f<\/span>Day 7<\/span><\/b>\u202fof\u202f<\/span>Week 1<\/span><\/b>.<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Discussion: Foundational Neuroscience<\/span>\u00a0<\/span><\/td>\n	Post by\u202f<\/span>Day 3\u202f<\/span><\/b>of<\/span>\u202fWeek 2<\/span><\/b>\u202fand respond to your colleagues by\u202f<\/span>Day 6\u202f<\/span><\/b>of<\/span>\u202fWeek 2<\/span><\/b>.<\/span>\u00a0<\/span><\/td>\n<\/tr>\n
Quiz: Neurobiology and Medication Adherence Concepts<\/span>\u00a0<\/span><\/td>\n	Complete Quiz by\u202f<\/span>Day 7<\/span><\/b>\u202fof\u202f<\/span>Week 3<\/span><\/b>.<\/span>\u00a0<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Go to the Weekly Content<\/span>\u00a0<\/span><\/p>\n A Sample Answer For the Assignment: NURS 6630 Self Assessment Neurobiology and Medication Adherence Concepts<\/strong><\/h2>\n Title: NURS 6630 Self Assessment Neurobiology and Medication Adherence Concepts<\/strong><\/h2>\n Question 1 <\/strong><\/h2>\n \n Which neurotransmitter<\/a> is considered the major excitatory neurotransmitter?<\/li>\n<\/ol>\n\n\n\n\n\n\n <\/td>\n A.<\/td>\n Glycine<\/td>\n<\/tr>\n <\/td>\n B.<\/td>\n GABA<\/td>\n<\/tr>\n <\/td>\n C.<\/td>\n Glutamate<\/td>\n<\/tr>\n <\/td>\n D.<\/td>\n Serotonin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n 0 points<\/p>\n Question 2 <\/strong><\/h2>\n \n The synaptic cleft is best characterized by which of the following statements?<\/li>\n<\/ol>\n\n\n\n\n\n <\/td>\n A.<\/td>\n The synaptic cleft is the space between a single neuron\u2019s dendrites and axon terminals in which intracellular communication occurs through the release of neurotransmitters allowing for signal conduction throughout the central nervous system.<\/td>\n<\/tr>\n <\/td>\n B.<\/td>\n The synaptic cleft is the space between the cell body and axon terminals that allows for release of neurotransmitters from the presynaptic neuron for intercellular communication with an adjacent neuron (post synaptic neuron).<\/td>\n<\/tr>\n <\/td>\n C.<\/td>\n The synaptic cleft is an area where dendrites and axon terminals are within close proximity, allowing for the release of a neurotransmitter from a presynaptic neuron that can interact with receptors on dendritic cells of a post synaptic neuron, which is the main basis for intercellular communication of neurons.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n 0 points<\/p>\n Question 3 <\/strong><\/h2>\n \n Which of the following consists of all the known major neurotransmitters that are relevant in psychiatry?<\/li>\n<\/ol>\n\n\n\n\n\n\n <\/td>\n A.<\/td>\n glutamate, GABA, dopamine, serotonin, norepinephrine, histamine, steroids, nitric oxide<\/td>\n<\/tr>\n <\/td>\n B.<\/td>\n glutamate, GABA, dopamine, norepinephrine, serotonin, acetylcholine, histamine, endogenous opioids, steroids, cannabinoids, nitric oxide<\/td>\n<\/tr>\n <\/td>\n C.<\/td>\n glutamate, GABA, dopamine, serotonin, acetylcholine, endogenous opioids, nitric oxide, cannabinoids, steroids<\/td>\n<\/tr>\n <\/td>\n D.<\/td>\n glutamate, GABA, dopamine, serotonin, norepinephrine, endogenous opioids, steroids, histamine, nitric oxide<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n 0 points<\/p>\n Question 4 <\/strong><\/h2>\n \n Receptors trigger one of two effector pathways resulting in changes in neuronal activity. These changes will, ultimately, effect gene expression. Which effector pathway is characterized by ion flux through transmitter-activated channels resulting in an altered membrane potential and neuronal activity?<\/li>\n<\/ol>\n\n\n\n\n\n\n <\/td>\n A.<\/td>\n Slow effector pathways<\/td>\n<\/tr>\n <\/td>\n B.<\/td>\n Modulated effector pathways<\/td>\n<\/tr>\n <\/td>\n C.<\/td>\n Rapid effector pathways<\/td>\n<\/tr>\n <\/td>\n D.<\/td>\n NMDA glutamate receptor pathways<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS: NURS 6630 Self Assessment Neurobiology and Medication Adherence Concepts<\/strong><\/a><\/em><\/span><\/h3>\n